BREWIN DOLPHIN LTD - INTEC PHARMA LTD JERUSALEM ownership

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2020$995
-11.2%
3,9550.0%0.00%
Q2 2020$1,120
+43.8%
3,9550.0%0.00%
Q1 2020$779
-60.6%
3,9550.0%0.00%
Q4 2019$1,978
-31.4%
3,9550.0%0.00%
Q3 2019$2,883
-78.4%
3,955
+28.6%
0.00%
-100.0%
Q2 2019$13,346
-21.0%
3,075
+33.4%
0.00%
-50.0%
Q1 2019$16,896
+26.6%
2,305
+30.2%
0.00%0.0%
Q4 2018$13,3461,7700.00%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 815,789$3,541,0001.78%
MEITAV INVESTMENT HOUSE LTD 2,460,136$10,651,0000.71%
DAFNA Capital Management LLC 415,989$1,805,0000.68%
KNOTT DAVID M 259,377$1,126,0000.48%
SECTORAL ASSET MANAGEMENT INC 879,000$3,815,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 620,000$2,691,0000.37%
ESSEX INVESTMENT MANAGEMENT CO LLC 283,434$1,230,0000.17%
Harel Insurance Investments & Financial Services Ltd. 624,809$2,711,0000.14%
Avoro Capital Advisors LLC 820,000$3,559,0000.12%
MENTA CAPITAL LLC 52,792$229,0000.10%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders